Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Vaccine Adjuvants Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Vaccine Adjuvants Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Vaccine Adjuvants Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Vaccine Adjuvants Market-Segmentation by Type 5.1 Mineral Salt Based Adjuvants 5.2 Tensoactive Adjuvants 5.3 Emulsions 5.4 Liposomes 5.5 Carbohydrates Adjuvants 5.6 Bacteria-Derived Adjuvants 5.7 Organic Adjuvants 5.8 Virus-Like Particles 5.9 Others 6 Global Vaccine Adjuvants Market-Segmentation by Application 6.1 Infectious Disease 6.2 Therapeutic 6.3 Others 7 Global Vaccine Adjuvants Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Seppic 8.1.1 Seppic Profile 8.1.2 Seppic Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Seppic Product/Solution Launches and Enhancements Analysis 8.1.4 Seppic Business Overview/Recent Development/Acquisitions 8.2 Oz Biosciences 8.2.1 Oz Biosciences Profile 8.2.2 Oz Biosciences Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Oz Biosciences Product/Solution Launches and Enhancements Analysis 8.2.4 Oz Biosciences Business Overview/Recent Development/Acquisitions 8.3 Adjuvance 8.3.1 Adjuvance Profile 8.3.2 Adjuvance Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Adjuvance Product/Solution Launches and Enhancements Analysis 8.3.4 Adjuvance Business Overview/Recent Development/Acquisitions 8.4 Merck KGaA 8.4.1 Merck KGaA Profile 8.4.2 Merck KGaA Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Merck KGaA Product/Solution Launches and Enhancements Analysis 8.4.4 Merck KGaA Business Overview/Recent Development/Acquisitions 8.5 InvivoGen 8.5.1 InvivoGen Profile 8.5.2 InvivoGen Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 InvivoGen Product/Solution Launches and Enhancements Analysis 8.5.4 InvivoGen Business Overview/Recent Development/Acquisitions 8.6 SPI Pharma 8.6.1 SPI Pharma Profile 8.6.2 SPI Pharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 SPI Pharma Product/Solution Launches and Enhancements Analysis 8.6.4 SPI Pharma Business Overview/Recent Development/Acquisitions 8.7 Aphios 8.7.1 Aphios Profile 8.7.2 Aphios Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Aphios Product/Solution Launches and Enhancements Analysis 8.7.4 Aphios Business Overview/Recent Development/Acquisitions 8.8 Agenus, Inc. 8.8.1 Agenus, Inc. Profile 8.8.2 Agenus, Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Agenus, Inc. Product/Solution Launches and Enhancements Analysis 8.8.4 Agenus, Inc. Business Overview/Recent Development/Acquisitions 8.9 Novavax 8.9.1 Novavax Profile 8.9.2 Novavax Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Novavax Product/Solution Launches and Enhancements Analysis 8.9.4 Novavax Business Overview/Recent Development/Acquisitions 8.10 Adjuvatis 8.10.1 Adjuvatis Profile 8.10.2 Adjuvatis Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Adjuvatis Product/Solution Launches and Enhancements Analysis 8.10.4 Adjuvatis Business Overview/Recent Development/Acquisitions 8.11 CSL Limited 8.11.1 CSL Limited Profile 8.11.2 CSL Limited Sales, Growth Rate and Global Market Share from 2014-2019E 8.11.3 CSL Limited Product/Solution Launches and Enhancements Analysis 8.11.4 CSL Limited Business Overview/Recent Development/Acquisitions 8.12 Brenntag AG 8.12.1 Brenntag AG Profile 8.12.2 Brenntag AG Sales, Growth Rate and Global Market Share from 2014-2019E 8.12.3 Brenntag AG Product/Solution Launches and Enhancements Analysis 8.12.4 Brenntag AG Business Overview/Recent Development/Acquisitions 8.13 Invivogen 8.13.1 Invivogen Profile 8.13.2 Invivogen Sales, Growth Rate and Global Market Share from 2014-2019E 8.13.3 Invivogen Product/Solution Launches and Enhancements Analysis 8.13.4 Invivogen Business Overview/Recent Development/Acquisitions 8.14 Vaxliant 8.14.1 Vaxliant Profile 8.14.2 Vaxliant Sales, Growth Rate and Global Market Share from 2014-2019E 8.14.3 Vaxliant Product/Solution Launches and Enhancements Analysis 8.14.4 Vaxliant Business Overview/Recent Development/Acquisitions 8.15 GlaxoSmithKline 8.15.1 GlaxoSmithKline Profile 8.15.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2014-2019E 8.15.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis 8.15.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions 8.16 Chemtrade Logistics 8.16.1 Chemtrade Logistics Profile 8.16.2 Chemtrade Logistics Sales, Growth Rate and Global Market Share from 2014-2019E 8.16.3 Chemtrade Logistics Product/Solution Launches and Enhancements Analysis 8.16.4 Chemtrade Logistics Business Overview/Recent Development/Acquisitions 9 Global Vaccine Adjuvants Market-Segmentation by Geography 10 North America 10.1 North America Vaccine Adjuvants Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Vaccine Adjuvants Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Vaccine Adjuvants Production Analysis from 2014-2019E 10.4 North America Vaccine Adjuvants Consumption Analysis from 2014-2019E 10.5 North America Vaccine Adjuvants Import and Export from 2014-2019E 10.6 North America Vaccine Adjuvants Value, Production and Market Share by Type (2014-2019E) 10.7 North America Vaccine Adjuvants Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Vaccine Adjuvants by Country (United States, Canada) 10.8.1 North America Vaccine Adjuvants Sales by Country (2014-2019E) 10.8.2 North America Vaccine Adjuvants Consumption Value by Country (2014-2019E) 10.9 North America Vaccine Adjuvants Market PEST Analysis 11 Europe 11.1 Europe Vaccine Adjuvants Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Vaccine Adjuvants Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Vaccine Adjuvants Production Analysis from 2014-2019E 11.4 Europe Vaccine Adjuvants Consumption Analysis from 2014-2019E 11.5 Europe Vaccine Adjuvants Import and Export from 2014-2019E 11.6 Europe Vaccine Adjuvants Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Vaccine Adjuvants Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Vaccine Adjuvants by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Vaccine Adjuvants Sales by Country (2014-2019E) 11.8.2 Europe Vaccine Adjuvants Consumption Value by Country (2014-2019E) 11.9 Europe Vaccine Adjuvants Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Vaccine Adjuvants Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Vaccine Adjuvants Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Vaccine Adjuvants Production Analysis from 2014-2019E 12.4 Asia-Pacific Vaccine Adjuvants Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Vaccine Adjuvants Import and Export from 2014-2019E 12.6 Asia-Pacific Vaccine Adjuvants Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Vaccine Adjuvants Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Vaccine Adjuvants by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Vaccine Adjuvants Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Vaccine Adjuvants Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Vaccine Adjuvants Market PEST Analysis 13 Latin America 13.1 Latin America Vaccine Adjuvants Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Vaccine Adjuvants Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Vaccine Adjuvants Production Analysis from 2014-2019E 13.4 Latin America Vaccine Adjuvants Consumption Analysis from 2014-2019E 13.5 Latin America Vaccine Adjuvants Import and Export from 2014-2019E 13.6 Latin America Vaccine Adjuvants Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Vaccine Adjuvants Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Vaccine Adjuvants by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Vaccine Adjuvants Sales by Country (2014-2019E) 13.8.2 Latin America Vaccine Adjuvants Consumption Value by Country (2014-2019E) 13.9 Latin America Vaccine Adjuvants Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Vaccine Adjuvants Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Vaccine Adjuvants Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Vaccine Adjuvants Production Analysis from 2014-2019E 14.4 Middle East & Africa Vaccine Adjuvants Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Vaccine Adjuvants Import and Export from 2014-2019E 14.6 Middle East & Africa Vaccine Adjuvants Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Vaccine Adjuvants Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Vaccine Adjuvants by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Vaccine Adjuvants Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Vaccine Adjuvants Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Vaccine Adjuvants Market PEST Analysis 15 Future Forecast of the Global Vaccine Adjuvants Market from 2018-2026 15.1 Future Forecast of the Global Vaccine Adjuvants Market from 2019-2026 Segment by Region 15.2 Global Vaccine Adjuvants Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Vaccine Adjuvants Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Vaccine Adjuvants Market Value ($) and Growth Rate of Vaccine Adjuvants from 2014-2026 Global Vaccine Adjuvants Production and Growth Rate Segment by Product Type from 2014-2026F Global Vaccine Adjuvants Consumption and Growth Rate Segment by Application from 2014-2019E Figure Vaccine Adjuvants Picture Table Product Specifications of Vaccine Adjuvants Table Driving Factors for this Market Table Industry News of Vaccine Adjuvants Market Figure Value Chain Status of Vaccine Adjuvants Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Vaccine Adjuvants Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Vaccine Adjuvants Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Mineral Salt Based Adjuvants of Vaccine Adjuvants Figure Tensoactive Adjuvants of Vaccine Adjuvants Figure Emulsions of Vaccine Adjuvants Figure Liposomes of Vaccine Adjuvants Figure Carbohydrates Adjuvants of Vaccine Adjuvants Figure Bacteria-Derived Adjuvants of Vaccine Adjuvants Figure Organic Adjuvants of Vaccine Adjuvants Figure Virus-Like Particles of Vaccine Adjuvants Figure Others of Vaccine Adjuvants Table Global Vaccine Adjuvants Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Vaccine Adjuvants Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Infectious Disease of Vaccine Adjuvants Figure Therapeutic of Vaccine Adjuvants Figure Others of Vaccine Adjuvants Table Global Vaccine Adjuvants Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Vaccine Adjuvants Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Vaccine Adjuvants Figure Online Channel of Vaccine Adjuvants Table Seppic Profile (Company Name, Plants Distribution, Sales Region) Figure Seppic Sales and Growth Rate from 2014-2019E Figure Seppic Revenue ($) and Global Market Share from 2014-2019E Table Seppic Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table Oz Biosciences Profile (Company Name, Plants Distribution, Sales Region) Figure Oz Biosciences Sales and Growth Rate from 2014-2019E Figure Oz Biosciences Revenue ($) and Global Market Share from 2014-2019E Table Oz Biosciences Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table Adjuvance Profile (Company Name, Plants Distribution, Sales Region) Figure Adjuvance Sales and Growth Rate from 2014-2019E Figure Adjuvance Revenue ($) and Global Market Share from 2014-2019E Table Adjuvance Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table Merck KGaA Profile (Company Name, Plants Distribution, Sales Region) Figure Merck KGaA Sales and Growth Rate from 2014-2019E Figure Merck KGaA Revenue ($) and Global Market Share from 2014-2019E Table Merck KGaA Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table InvivoGen Profile (Company Name, Plants Distribution, Sales Region) Figure InvivoGen Sales and Growth Rate from 2014-2019E Figure InvivoGen Revenue ($) and Global Market Share from 2014-2019E Table InvivoGen Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table SPI Pharma Profile (Company Name, Plants Distribution, Sales Region) Figure SPI Pharma Sales and Growth Rate from 2014-2019E Figure SPI Pharma Revenue ($) and Global Market Share from 2014-2019E Table SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table Aphios Profile (Company Name, Plants Distribution, Sales Region) Figure Aphios Sales and Growth Rate from 2014-2019E Figure Aphios Revenue ($) and Global Market Share from 2014-2019E Table Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table Agenus, Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Agenus, Inc. Sales and Growth Rate from 2014-2019E Figure Agenus, Inc. Revenue ($) and Global Market Share from 2014-2019E Table Agenus, Inc. Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table Novavax Profile (Company Name, Plants Distribution, Sales Region) Figure Novavax Sales and Growth Rate from 2014-2019E Figure Novavax Revenue ($) and Global Market Share from 2014-2019E Table Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table Adjuvatis Profile (Company Name, Plants Distribution, Sales Region) Figure Adjuvatis Sales and Growth Rate from 2014-2019E Figure Adjuvatis Revenue ($) and Global Market Share from 2014-2019E Table Adjuvatis Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table CSL Limited Profile (Company Name, Plants Distribution, Sales Region) Figure CSL Limited Sales and Growth Rate from 2014-2019E Figure CSL Limited Revenue ($) and Global Market Share from 2014-2019E Table CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table Brenntag AG Profile (Company Name, Plants Distribution, Sales Region) Figure Brenntag AG Sales and Growth Rate from 2014-2019E Figure Brenntag AG Revenue ($) and Global Market Share from 2014-2019E Table Brenntag AG Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table Invivogen Profile (Company Name, Plants Distribution, Sales Region) Figure Invivogen Sales and Growth Rate from 2014-2019E Figure Invivogen Revenue ($) and Global Market Share from 2014-2019E Table Invivogen Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table Vaxliant Profile (Company Name, Plants Distribution, Sales Region) Figure Vaxliant Sales and Growth Rate from 2014-2019E Figure Vaxliant Revenue ($) and Global Market Share from 2014-2019E Table Vaxliant Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table GlaxoSmithKline Profile (Company Name, Plants Distribution, Sales Region) Figure GlaxoSmithKline Sales and Growth Rate from 2014-2019E Figure GlaxoSmithKline Revenue ($) and Global Market Share from 2014-2019E Table GlaxoSmithKline Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table Chemtrade Logistics Profile (Company Name, Plants Distribution, Sales Region) Figure Chemtrade Logistics Sales and Growth Rate from 2014-2019E Figure Chemtrade Logistics Revenue ($) and Global Market Share from 2014-2019E Table Chemtrade Logistics Vaccine Adjuvants Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Vaccine Adjuvants Production Value ($) by Region from 2014-2019E Table Global Vaccine Adjuvants Production Value Share by Region from 2014-2019E Table Global Vaccine Adjuvants Production by Region from 2014-2019E Table Global Vaccine Adjuvants Consumption Value ($) by Region from 2014-2019E Table Global Vaccine Adjuvants Consumption by Region from 2014-2019E Table North America Vaccine Adjuvants Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Vaccine Adjuvants Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Vaccine Adjuvants Import and Export from 2014-2019E Table North America Vaccine Adjuvants Value ($) by Type (2014-2019E) Table North America Vaccine Adjuvants Production by Type (2014-2019E) Table North America Vaccine Adjuvants Consumption by Application (2014-2019E) Table North America Vaccine Adjuvants Consumption by Country (2014-2019E) Table North America Vaccine Adjuvants Consumption Value ($) by Country (2014-2019E) Figure North America Vaccine Adjuvants Market PEST Analysis Table Europe Vaccine Adjuvants Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Vaccine Adjuvants Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Vaccine Adjuvants Import and Export from 2014-2019E Table Europe Vaccine Adjuvants Value ($) by Type (2014-2019E) Table Europe Vaccine Adjuvants Production by Type (2014-2019E) Table Europe Vaccine Adjuvants Consumption by Application (2014-2019E) Table Europe Vaccine Adjuvants Consumption by Country (2014-2019E) Table Europe Vaccine Adjuvants Consumption Value ($) by Country (2014-2019E) Figure Europe Vaccine Adjuvants Market PEST Analysis Table Asia-Pacific Vaccine Adjuvants Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Vaccine Adjuvants Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Vaccine Adjuvants Import and Export from 2014-2019E Table Asia-Pacific Vaccine Adjuvants Value ($) by Type (2014-2019E) Table Asia-Pacific Vaccine Adjuvants Production by Type (2014-2019E) Table Asia-Pacific Vaccine Adjuvants Consumption by Application (2014-2019E) Table Asia-Pacific Vaccine Adjuvants Consumption by Country (2014-2019E) Table Asia-Pacific Vaccine Adjuvants Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Vaccine Adjuvants Market PEST Analysis Table Latin America Vaccine Adjuvants Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Vaccine Adjuvants Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Vaccine Adjuvants Import and Export from 2014-2019E Table Latin America Vaccine Adjuvants Value ($) by Type (2014-2019E) Table Latin America Vaccine Adjuvants Production by Type (2014-2019E) Table Latin America Vaccine Adjuvants Consumption by Application (2014-2019E) Table Latin America Vaccine Adjuvants Consumption by Country (2014-2019E) Table Latin America Vaccine Adjuvants Consumption Value ($) by Country (2014-2019E) Figure Latin America Vaccine Adjuvants Market PEST Analysis Table Middle East & Africa Vaccine Adjuvants Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Vaccine Adjuvants Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Vaccine Adjuvants Import and Export from 2014-2019E Table Middle East & Africa Vaccine Adjuvants Value ($) by Type (2014-2019E) Table Middle East & Africa Vaccine Adjuvants Production by Type (2014-2019E) Table Middle East & Africa Vaccine Adjuvants Consumption by Application (2014-2019E) Table Middle East & Africa Vaccine Adjuvants Consumption by Country (2014-2019E) Table Middle East & Africa Vaccine Adjuvants Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Vaccine Adjuvants Market PEST Analysis Table Global Vaccine Adjuvants Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Vaccine Adjuvants Production and Growth Rate Forecast by Region (2019-2026) Table Global Vaccine Adjuvants Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Vaccine Adjuvants Production and Growth Rate Forecast by Type (2019-2026) Table Global Vaccine Adjuvants Consumption and Growth Rate Forecast by Application (2019-2026)